CardiOCare's project logo

An Interdisciplinary Approach for the Management of the Elderly Multimorbid Patient with Breast Cancer Therapy Induced Cardiac Toxicity

CARDIOCARE in the ESC Congress 2024

Sep 1, 2024

CARDIOCARE participated in the ESC Congress 2024 with a scientific session entitled “Preventing breast cancer cardiotoxicity with CARDIOCARE“. In this session the latest advances in breast cancer and cardiotoxicity were presented and how the technology can decrease cardiotoxicity in breast cancer was discussed.

Chairpersons
Julia Toste Batista Joaquinito (Hospital da Luz, SA – Lisbon, Portugal)
Markus Anker (Charité – University Medicine Berlin – Berlin, Germany)

Presentations
Breast cancer and cardiotoxicity: an update / Speaker: Kalliopi Keramida (Agios Savvas General Oncology Hospital – Athens, Greece)
How the technology can decrease cardiotoxicity in breast cancer / Speaker: Irene Marco Clement (San Carlos Clinical University Hospital – Madrid, Spain)
CARDIOCARE: an interdisciplinary approach for the management of the elderly multimorbid patient with breast cancer therapy-induced cardiac toxicity / Speaker: Dimitrios Fotiadis (University of Ioannina – Ioannina, Greece)

More information on the session: https://esc365.escardio.org/ESC-Congress/sessions/12198

Highlights

New CARDIOCARE Podcast: Cardiotoxicity and Multi-Source Information

New CARDIOCARE Podcast: Cardiotoxicity and Multi-Source Information

The second podcast of CARDIOCARE entitled "Cardiotoxicity & Multi-Source Information" is available on the YouTube channel of the project.   In this podcast, Professor D. Fotiadis and Professor K. Naka from the University of Ioannina (Greece) explore the...

New Video Alert: Redefining Cardio-Oncology for Real-World Patients

New Video Alert: Redefining Cardio-Oncology for Real-World Patients

CARDIOCARE proudly presents our latest video — “CARDIOCARE: Redefining Cardio-Oncology for Real-World Patients”. This initiative reflects our unwavering commitment to advancing integrated, patient-centered care for individuals facing both cardiovascular disease and...